- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07807735
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD) (MDD)
September 2, 2026 updated by: Edward Via Virginia College of Osteopathic Medicine
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression.
The Program Enrolls Children With Diagnosis of Major Depressive Disorder, Through Use of Virtual Reality and Education, We Are Measuring Effectiveness of the Program Through Use of PHQ9-A and GAD7.
(MDD)
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lindsey Van Duyn, DO
- Phone Number: 3193334354
- Email: support@immersivemedicaltherapy.com
Study Contact Backup
- Name: James Mahaney, PhD
- Email: jmahaney@vt.vcom.edu
Study Locations
-
-
Iowa
-
Washington, Iowa, United States, 52353
- Auroura Counseling
-
Contact:
- Lindsey Van Duyn, DO
- Phone Number: 3193334354
- Email: support@immersivemedicaltherapy.com
-
Contact:
- James Mahaney, PhD
- Email: jmahaney@vt.vcom.edu
-
Principal Investigator:
- Lindsey Van Duyn, DO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
-
Exclusion Criteria:
- A patient that has been started on an antidepressant medication within the last 8 weeks.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 10 adolescents with diagnosis of depression
This is a single arm study for effectiveness.
10 adolescents will be enrolled in first study.
|
We will use a combination of virtual reality experiences and educational experiences.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Virtual Reality use helps teens with depression
Time Frame: 8 weeks
|
Using PHQ9 scores, does this program help improve their depression scores?
|
8 weeks
|
|
Virtual Reality use helps teens with anxiety
Time Frame: 8 weeks
|
Using GAD7 scores, does this program help improve their anxiety scores?
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lindsey Van Duyn, DO, Edward Via College of Osteopathic Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Study Registration Dates
First Submitted
September 2, 2026
First Submitted That Met QC Criteria
September 2, 2026
First Posted (Actual)
September 8, 2026
Study Record Updates
Last Update Posted (Actual)
September 8, 2026
Last Update Submitted That Met QC Criteria
September 2, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2270964
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.